Clinical Trials for IPMN, Pancreatic

Impact of GLP-1 Receptor Agonists on Patients With IPMN

NCT ID: NCT07014709

This clinical trial is looking at how a group of medications called GLP-1 receptor agonists (GLP-1 RAs) might affect patients who have a condition known as intraductal papillary mucinous neoplasms ...

The LINFU® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas)

NCT ID: NCT06276764

Integration of Multiomics Markers for Invasive IPMNs Identification Through the Set-up of the INvasive Cyst BIomarkers Detection (INCITE) Consortium

NCT ID: NCT06694792

The INCITE trial is focused on improving how we identify invasive intraductal papillary mucinous neoplasms (IPMNs), which are growths in the pancreas that could lead to pancreatic cancer. Researche...

Pancreatic Cancer Initial Detection Via Liquid Biopsy

NCT ID: NCT06283576

Intraductal Papillary Mucinous Neoplasm (IPMN) Database - A Tool to Predict Pancreatic Cancer

NCT ID: NCT05117723

This clinical trial is focused on understanding how a specific type of pancreatic condition called Intraductal Papillary Mucinous Neoplasm (IPMN) can progress to pancreatic cancer. The goal is to g...

A Long-term Follow-up Cohort Study in Patients With Intraductal Papillary Mucinous Neoplasm

NCT ID: NCT05593393

This clinical trial is looking to follow patients with a condition called intraductal papillary mucinous neoplasm (IPMN), which is a type of cystic tumor in the pancreas. The main goal of the study...